Uncategorized

30Dec 2017

It is becoming increasingly common that early stage drug candidates have potential applications in several therapy areas. This is especially prevalent where several diseases share a similar etiology. Areas such as immunology, oncology and metabolic disorders can have ailments that are characterized by different physiological involvement but share a similar underlying cause. Numerous medicines currently […]

14Sep 2017

A recently published study by Dyer O has exposed major drawbacks in the fast tracking process of some drugs available to the American patients without any stringent clinical evidence of their benefits. Drugs that receive accelerated approvals from the US Food and Drug Administration (FDA) often rest on a flawed evidence base, says research that evaluated […]

10Apr 2017

Bioresorbable stents have effectively been pulled from the European market by Abbott and will now be available only in “clinical registry setting at select sites/institutions” in Europe, where they will be monitored till a review in 2018. India has been among the largest markets for these stents in recent years. The development comes in the […]

06Mar 2017

Clinical research includes the traditional prospective clinical trials, cohort studies, and case-control studies, while outcomes research (OR) has now solidified itself as a separate class of clinical research. OR is an evolving and critical part of health sciences research due to its focus on the improvement of patient care in the practice setting. Evidence included […]